A large study into rare blood clots linked with AstraZeneca’s COVID-19 vaccine found between just one and three cases per million, and only after the first dose, shedding fresh light…
Gennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure Pharmaceuticals, is developing a Covid-19 vaccine on its mRNA platform which will target the Omicron variant, the strain that is driving the…
Australian Health Minister Greg Hunt said last week he expects the Australian Technical Advisory Group on Immunisation (ATAGI) to change the definition of “fully vaccinated” to three doses instead of…
The “nocebo effect” accounted for more than two-thirds of the common side effects people experience after a Covid-19 vaccination rather than the vaccine itself, according to a new study. The…
PATNA: Even as senior citizens and health workers are being administered booster doses at different health centres in the city, people with a recent breakthrough infection are not sure whether…
By Sheena Cruickshank, Professor in Biomedical Sciences, University of Manchester With omicron having rapidly driven up COVID infections, attention is once again focusing on antibodies, and reasonably so. They play…
The Tata Medical and Diagnostics has developed a kit ‘OmiSure’ that can detect the Omicron variant of SARS-CoV2 in nasopharyngeal/oropharyngeal specimens during the RT-PCR tests, a senior company executive said…
Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February…
How do scientists detect new variants of the virus that causes COVID-19? The answer is a process called DNA sequencing. Researchers sequence DNA to determine the order of the four…
PATNA: In the wake of Omicron threat, health experts are worried over the increasing and indiscriminate misuse of antibiotics, which has not only been weakening gut immunity but also making…
